ArticleClinical epigenetics2025

Tumors with mutations in chromatin regulators are associated with higher mutational burden and improved response to checkpoint immunotherapy.

Marija Gjorgjievska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.